Drug Channels

JUNE 27, 2021

As you declare your vaccinated independence, celebrate with these Drug Channels fireworks: Amazon’s teeny step toward pharmacy disruption How patients view copay accumulators My $0.02 on generic and biosimilar trends Some hospitals seem to be gaming their 340B eligibility Plus, tips on effective hospital marketing.

Biosimilars 52

Biosimilars Hospitals Pharmacy Vaccine 52

Drug Channels

FEBRUARY 22, 2022

New sections cover: pharmacies’ administration of—and profits from—COVID-19 vaccines; smaller PBMs; PBM purchasing groups and GPOs; 340b split-billing software vendors; and shakeout and consolidation within retail pharmacy. We also present a more unified outlook for specialty drugs, including specialty generics and biosimilars.

Pharmacy 96

Pharmacy Specialty Pharmacies Biosimilars Licensing 96

Drug Channels

OCTOBER 10, 2023

Drug Distribution Industry Gaining from Anti-Obesity Drugs and Provider-Administered Biosimilars (press release) We’re offering special discounted pricing if you order before October 20, 2023! which examines the distribution of COVID-19 vaccines and therapeutics. Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

DECEMBER 1, 2020

If all goes well, 2021 will begin our return to normalcy, as vaccines roll out across the country. They are now poised to play a vital role in distributing COVID-19 vaccines and therapeutics as they become available. Read more » Copyright © 2006-2020 Pembroke Consulting, Inc. distribution channels for prescription drugs.

Pharmacy 52

Pharmacy Vaccine Drugs Pharmaceuticals 52

The Pharma Data

MAY 15, 2023

Before joining Solvias Group, Karen held various senior leadership roles at Novartis, including global head investor relations from 2000 to 2006, head M&A and Executive Committee member, as well as site head for the Vaccines & Diagnostics division between 2006 and 2011.

Science 40

Science Doctors Government Compliance 40

The Pharma Data

JULY 15, 2021

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. UK Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the UK.

Disease 52

Disease Biosimilars Government Treatment 52

The Pharma Data

JULY 8, 2021

We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. UK Biobank recruited 500,000 people aged between 40-69 years in 2006-2010 from across the UK.

Disease 52

Disease Government Clinical Trials Research 52